Współczesna Onkologia

 
3/2026 vol. 30
Radiotherapy and immunotherapy in oligometastatic lung cancer: toward an optimal therapeutic balance – a narrative review

Review paper

Contemp Oncol (Pozn) 2026; 30 (3): 189–197

DOI: https://doi.org/10.5114/wo.2026.164740
Abstract View text (PDF)
Ophthalmic complications associated with chimeric antigen receptor T-cell therapy: a review of current evidence

Review paper

Contemp Oncol (Pozn) 2026; 30 (3): 198–205

DOI: https://doi.org/10.5114/wo.2026.165736
Abstract View text (PDF)
Precision oncology for lung cancer in the Federation of Bosnia and Herzegovina: current access and unmet needs

Review paper

Contemp Oncol (Pozn) 2026; 30 (3): 206–215

DOI: https://doi.org/10.5114/wo.2026.165636
Abstract View text (PDF)
Clinical applications of artificial intelligence in oncology treatment planning

Review paper

Contemp Oncol (Pozn) 2026; 30 (3): 216–228

DOI: https://doi.org/10.5114/wo.2026.165835
Abstract View text (PDF)
Baseline values and dynamic changes of inflammatory indices are not prognostic for progressionfree survival in first-line pembrolizumab plus chemotherapy for programmed death-ligand 1-positive advanced triple-negative breast cancer: a Polish multicenter cohort study

Original paper

Contemp Oncol (Pozn) 2026; 30 (3): 229–238

DOI: https://doi.org/10.5114/wo.2026.165963
Abstract View text (PDF)
Surgical treatment of retroperitoneal sarcomas: analysis of multi-organ resections and factors influencing perioperative outcomes

Original paper

Contemp Oncol (Pozn) 2026; 30 (3): 249–254

DOI: https://doi.org/10.5114/wo.2026.166046
Abstract View text (PDF)
Chloride intracellular channels engage in head and neck squamous cell carcinoma pathogenesis: a bioinformatic exploration of expression patterns, immune interactions, and oncogenic pathways

Original paper

Contemp Oncol (Pozn) 2026; 30 (3): 255–270

DOI: https://doi.org/10.5114/wo.2026.165538
Abstract View text (PDF)
Evaluation of the utility of whole-exome sequencing in patients with atypical clinical features of oncohematologic diseases

Original paper

Contemp Oncol (Pozn) 2026; 30 (3): 271–276

DOI: https://doi.org/10.5114/wo.2026.164606
Abstract View text (PDF)
Radiation-associated sarcomatoid carcinoma of the larynx as a late complication of papillary thyroid cancer treatment

Case report

Contemp Oncol (Pozn) 2026; 30 (3): 290–294

DOI: https://doi.org/10.5114/wo.2026.165346
Abstract View text (PDF)
Looking for personalised treatments in chordoma: benefit of olaparib in a <em>BRCA2</em>-mutated patient

Case report

Contemp Oncol (Pozn) 2026; 30 (3): 295–300

DOI: https://doi.org/10.5114/wo.2026.165741
Abstract View text (PDF)
Molecularly guided treatment in recurrent mucinous ovarian carcinoma

Case report

Contemp Oncol (Pozn) 2026; 30 (3): 301 –306

DOI: https://doi.org/10.5114/wo.2026.163809
Abstract View text (PDF)